SOPHIA GENETICS SA
(NASDAQ: SOPH)

SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.

3.580

+0.210 (+6.23%)
Range 3.410 - 3.840   (12.61%)
Open 3.450
Previous Close 3.370
Bid Price 4.950
Bid Volume 10
Ask Price 5.250
Ask Volume 18
Volume 84,053
Value -
Remark
Delayed prices. Updated at 01 Nov 2024 04:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis